Provision of Nasal Naloxone
Complete · United Kingdom · Last reported Nov 2025
Source: GOV.UK
The provision including supply and delivery of nasal Naloxone. Nasal Naloxone supplied must be licensed for use in the UK, compliant with Medicines and Healthcare products Regulatory Agency (MHRA) standards and of a formulation licensed for use on adults and adolescents aged 14 and over. Timely ...
- Status
- Closed
- Sector
- Government, Road, Hospital
- Location
- United Kingdom
- Updated
- 3 Nov 2026
- Source
- GOV.UK
ConstructChat
Ask ConstructChat about Provision of Nasal Naloxone
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | complete |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | The provision including supply and delivery of nasal Naloxone. Nasal Naloxone supplied must be licensed for use in the UK, compliant with Medicines and Healthcare products Regulatory Agency (MHRA) standards and of a formulation licensed for use on adults and adolescents aged 14 and over. Timely ... |
Budget |
Location
Country | United Kingdom (UK) |
Source
Source | GOV.UK |
URL |
More Details
Record type | Tender |
Sector | Government, Road, Hospital |
Article published date | 2025-11-14 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender
